{"pmid":32504061,"title":"SARS-CoV-2 cross-reactivity in healthy donors.","text":["SARS-CoV-2 cross-reactivity in healthy donors.","Nat Rev Immunol","van der Heide, Verena","32504061"],"journal":"Nat Rev Immunol","authors":["van der Heide, Verena"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504061","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41577-020-0362-x","topics":["Mechanism"],"weight":1,"_version_":1668892488331427841,"score":9.490897,"similar":[{"pmid":32355329,"pmcid":"PMC7192054","title":"SARS-CoV-2-reactive T cells in patients and healthy donors.","text":["SARS-CoV-2-reactive T cells in patients and healthy donors.","Nat Rev Immunol","Pia, Luisanna","32355329"],"journal":"Nat Rev Immunol","authors":["Pia, Luisanna"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32355329","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41577-020-0333-2","topics":["Mechanism"],"weight":1,"_version_":1666138495265013760,"score":48.42171},{"pmid":32426212,"pmcid":"PMC7231734","title":"Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.","text":["Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.","The World Health Organization has declared the ongoing outbreak of COVID-19, which is caused by a novel coronavirus SARS-CoV-2, as pandemic. There is currently a lack of knowledge about the antibody response elicited from SARS-CoV-2 infection. One major immunological question concerns antigenic differences between SARS-CoV-2 and SARS-CoV. We address this question by analyzing plasma from patients infected by SARS-CoV-2 or SARS-CoV, and from infected or immunized mice. Our results show that, while cross-reactivity in antibody binding to the spike protein is common, cross-neutralization of the live viruses may be rare, indicating the presence of non-neutralizing antibody response to conserved epitopes in the spike. Whether such low or non-neutralizing antibody response leads to antibody-dependent disease enhancement needs to be addressed in the future. Overall, this study not only addresses a fundamental question regarding antigenicity differences between SARS-CoV-2 and SARS-CoV, but also has implications for immunogen design and vaccine development.","Cell Rep","Lv, Huibin","Wu, Nicholas C","Tak-Yin Tsang, Owen","Yuan, Meng","Perera, Ranawaka A P M","Leung, Wai Shing","So, Ray T Y","Chun Chan, Jacky Man","Yip, Garrick K","Hong Chik, Thomas Shiu","Wang, Yiquan","Chung Choi, Chris Yau","Lin, Yihan","Ng, Wilson W","Zhao, Jincun","Poon, Leo L M","Peiris, J S Malik","Wilson, Ian A","Mok, Chris K P","32426212"],"abstract":["The World Health Organization has declared the ongoing outbreak of COVID-19, which is caused by a novel coronavirus SARS-CoV-2, as pandemic. There is currently a lack of knowledge about the antibody response elicited from SARS-CoV-2 infection. One major immunological question concerns antigenic differences between SARS-CoV-2 and SARS-CoV. We address this question by analyzing plasma from patients infected by SARS-CoV-2 or SARS-CoV, and from infected or immunized mice. Our results show that, while cross-reactivity in antibody binding to the spike protein is common, cross-neutralization of the live viruses may be rare, indicating the presence of non-neutralizing antibody response to conserved epitopes in the spike. Whether such low or non-neutralizing antibody response leads to antibody-dependent disease enhancement needs to be addressed in the future. Overall, this study not only addresses a fundamental question regarding antigenicity differences between SARS-CoV-2 and SARS-CoV, but also has implications for immunogen design and vaccine development."],"journal":"Cell Rep","authors":["Lv, Huibin","Wu, Nicholas C","Tak-Yin Tsang, Owen","Yuan, Meng","Perera, Ranawaka A P M","Leung, Wai Shing","So, Ray T Y","Chun Chan, Jacky Man","Yip, Garrick K","Hong Chik, Thomas Shiu","Wang, Yiquan","Chung Choi, Chris Yau","Lin, Yihan","Ng, Wilson W","Zhao, Jincun","Poon, Leo L M","Peiris, J S Malik","Wilson, Ian A","Mok, Chris K P"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426212","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.celrep.2020.107725","topics":["Treatment","Mechanism"],"weight":1,"_version_":1667352728782766083,"score":40.571133}]}